IDEOM stakeholders: Join us on June 17th & 18th for the IDEOM annual meeting in Washington, DC. Check your email for a link to register. We look forward to seeing you there!
To remain eligible for travel reimbursement for all future in-person meetings, all stakeholders MUST attend the two (2) days of the virtual annual meeting in its entirety.
CALL FOR ABSTRACTS
The IDEOM Board of Directors will select abstracts for poster presentation at the 2022 Annual Meeting. Posters will be available for viewing at the Annual Meeting during designated breaks. There will not be an opportunity to present at the podium during working meetings.
DEADLINE: Friday, April 15, 2022
IDEOM Annual Meeting 2021
November 19 - 20, 2021
The IDEOM Annual Meeting is open to all IDEOM stakeholders. If you are not an IDEOM stakeholder, please contact Amanda Pacia at firstname.lastname@example.org to learn more.
IDEOM at GRAPPA 2021
July 8, 2021
This meeting is intended for all IDEOM Psoriatic Disease stakeholders and all GRAPPA members. IDEOM will present an overview and PsA Musculoskeletal Symptoms Workgroup projects.
IDEOM Annual Meeting 2020
Original Meeting Rescheduled Due to Covid 19
New Date: October 23-24, 2020
Friday May 5 & Saturday May 6, 2017
The Mayflower Hotel
1127 Connecticut Avenue NW
2016 Ideom Annual Meeting
March 2, 2016
Westin Washington, DC City Center
1400 M St NW
Washington, DC 20005
The annual meeting of IDEOM was held on March 2, 2016, at the Westin Washington, DC City Center in Washington DC. After anintroduction about what IDEOM does, the meeting continued with Leah Howard, from the National Psoriasis Foundation (NPF),presenting data on how payers assess quality of treatments in psoriasis. Then, Dr. Kendall Marcus, Head of the U.S. Food and Drug Administration’s (FDA) Dermatology Division, gave a presentation on outcomes in dermatology. The rest of the morning and part of the afternoon showcased results of our most recent DELPHI exercise. We did live DELPHI exercises at this meeting and hopefully will choose our final list of domains and discuss next steps. During lunch and breaks, attendees were able to view posters containing submitted outcomes research in dermatology. Towards the latter part of the afternoon, the Hidradenitis Suppurativa (HS) working group discussed its goals and next steps. The Acne Outcomes Research Group (ACORN) presented their work and discussed how IDEOM can help them in their efforts.